| Nom |
Tadalafil |
| Nom anglais |
Tadalafil; IC-351; (6r,12ar)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; Cialis; (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-3,4,6,6a,7,11b,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-1(2H)-one; Tadanafil |
| Formule moléculaire |
C22H23N3O3 |
| Poids Moléculaire |
377.44 |
| InChI |
InChI=1/C22H23N3O3/c1-24-8-9-25-17(22(24)26)11-15-14-4-2-3-5-16(14)23-20(15)21(25)13-6-7-18-19(10-13)28-12-27-18/h2-7,10,15,17,20-21,23H,8-9,11-12H2,1H3/t15?,17-,20?,21-/m1/s1 |
| Numéro de registre CAS |
171596-29-5 |
| Structure moléculaire |
|
| Densité |
1.4g/cm3 |
| Point d'ébullition |
569.9°C at 760 mmHg |
| Indice de réfraction |
1.705 |
| Point d'éclair |
298.5°C |
| Pression de vapeur |
5.29E-13mmHg at 25°C |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
